BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Hepatitis C virus
1
Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus
3/20/2019 5:32:10 AM | Browse: 28 | Download: 28
2
Necrolytic acral erythema in a human immunodeficiency virus/hepatitis C virus coinfected patient: A case report
2/26/2019 11:29:06 AM | Browse: 49 | Download: 27
3
Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression
1/26/2019 11:40:14 AM | Browse: 55 | Download: 17
4
Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma
1/7/2019 10:39:41 AM | Browse: 56 | Download: 39
5
Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
12/27/2018 9:28:07 AM | Browse: 42 | Download: 30
6
Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions
12/6/2018 1:35:45 PM | Browse: 87 | Download: 27
7
Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients
11/27/2018 1:56:41 PM | Browse: 45 | Download: 20
8
Mononuclear phagocyte system in hepatitis C virus infection
11/27/2018 5:55:53 AM | Browse: 62 | Download: 25
9
Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?
11/7/2018 2:30:08 AM | Browse: 82 | Download: 46
10
Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir
10/26/2018 11:38:21 AM | Browse: 56 | Download: 33
11
Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations
10/12/2018 5:32:21 AM | Browse: 74 | Download: 45
12
Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c
9/27/2018 9:38:46 AM | Browse: 112 | Download: 73
13
Challenge of hepatitis C in Egypt and hepatitis B in Mauritania
9/27/2018 9:38:46 AM | Browse: 92 | Download: 44
14
Epidemiology of viral hepatitis in Somalia: Systematic review and meta-analysis study
9/14/2018 5:53:04 AM | Browse: 88 | Download: 28
15
Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis
8/27/2018 7:22:43 AM | Browse: 120 | Download: 51
16
Form confers function: Case of the 3’X region of the hepatitis C virus genome
8/13/2018 7:45:11 AM | Browse: 90 | Download: 42
17
Hepatitis C and renal transplantation in era of new antiviral agents
8/9/2018 8:05:57 AM | Browse: 100 | Download: 36
18
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions
6/28/2018 2:47:35 AM | Browse: 176 | Download: 95
19
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows
6/26/2018 12:26:34 AM | Browse: 131 | Download: 75
20
Hepatitis C virus infection in children in the era of direct-acting antiviral
6/26/2018 12:26:34 AM | Browse: 148 | Download: 90
21
Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus
4/4/2018 1:15:45 PM | Browse: 183 | Download: 115
22
Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus
3/26/2018 8:48:04 AM | Browse: 160 | Download: 71
23
Cell culture-adaptive mutations in hepatitis C virus promote viral production by enhancing viral replication and release
3/26/2018 8:48:04 AM | Browse: 138 | Download: 48
24
Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions
3/16/2018 12:27:25 PM | Browse: 181 | Download: 67
25
Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents
3/4/2018 12:36:47 PM | Browse: 141 | Download: 44
26
Hepatitis C virus: Morphogenesis, infection and therapy
3/4/2018 12:36:47 PM | Browse: 187 | Download: 101
27
High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016
1/26/2018 8:09:36 AM | Browse: 206 | Download: 174
28
Role of inflammatory response in liver diseases: Therapeutic strategies
1/26/2018 8:09:36 AM | Browse: 225 | Download: 127
29
Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
1/19/2018 9:46:49 AM | Browse: 231 | Download: 60
30
Hepatitis C virus core protein-induced miR-93-5p inhibits IFN signaling pathway through targeting IFNAR1
1/14/2018 5:07:58 AM | Browse: 201 | Download: 117
31
Correlation between smoking habit and surgical outcomes on viral-associated hepatocellular carcinomas
1/7/2018 4:21:05 AM | Browse: 249 | Download: 125
32
Estrogen, estrogen receptors, and hepatocellular carcinoma: are we there yet?
1/7/2018 4:21:04 AM | Browse: 204 | Download: 76
33
Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection
12/27/2017 10:31:19 AM | Browse: 194 | Download: 67
34
Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b
12/12/2017 8:34:13 AM | Browse: 207 | Download: 93
35
Global elimination of hepatitis C virus infection: Progresses and the remaining challenges
11/24/2017 12:22:15 AM | Browse: 283 | Download: 168
36
Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection
8/28/2017 6:54:48 AM | Browse: 321 | Download: 396
37
(-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes
8/28/2017 6:54:48 AM | Browse: 239 | Download: 316
38
Lurking epidemic of hepatitis C virus infection in Iran: A call to action
8/25/2017 1:53:29 AM | Browse: 247 | Download: 164
39
Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
8/19/2017 11:33:53 AM | Browse: 173 | Download: 182
40
Single amino acid mutation of SR-BI decreases infectivity of hepatitis C virus derived from cell culture in a cell culture model
7/28/2017 8:16:18 AM | Browse: 205 | Download: 650
41
Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: A single-center study
7/17/2017 11:13:33 PM | Browse: 192 | Download: 236
42
Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease
7/5/2017 4:40:07 AM | Browse: 250 | Download: 340
43
Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C
6/7/2017 7:22:42 AM | Browse: 561 | Download: 1365
44
Matrix metalloproteases and their tissue inhibitors in non-alcoholic liver fibrosis of human immunodeficiency virus-infected patients
5/12/2017 10:16:48 PM | Browse: 260 | Download: 472
45
Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection
4/13/2017 3:45:15 PM | Browse: 288 | Download: 445
46
Efficacy and safety of dual therapy with daclatasvir and asunaprevir in elderly patients
4/13/2017 3:45:15 PM | Browse: 297 | Download: 293
47
Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients
3/24/2017 9:18:00 AM | Browse: 398 | Download: 660
48
Mortality associated with hepatitis C and hepatitis B virus infection: A nationwide study on multiple causes of death data
3/13/2017 7:05:00 PM | Browse: 373 | Download: 486
49
Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C
3/13/2017 1:20:00 PM | Browse: 330 | Download: 594
50
Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review
3/6/2017 1:27:00 PM | Browse: 434 | Download: 459
Write to the Help Desk
© 2004-2018 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345